TDSPHARM Co., Ltd. Logo

TDSPHARM Co., Ltd.

Develops and manufactures transdermal drug delivery systems like patches, plasters, and OTC products.

464280 | KO

Overview

Corporate Details

ISIN(s):
KR7464280007
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 판교로 253 C동 403호, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

TDSPHARM Co., Ltd. is a pharmaceutical company specializing in the research, development, and manufacturing of Transdermal Drug Delivery Systems (TDDS). Founded in 2002, the company leverages its expertise in TDDS technology to produce a range of products, including medical cataplasmas, plasters, and patches. Its portfolio also encompasses over-the-counter (OTC) medicines and cosmetic products. The company is committed to R&D to deliver safe and efficient medicinal products that are absorbed through the skin, with a goal of providing accessible healthcare solutions to consumers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 86.7 KB
2025-09-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 814.7 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 783.5 KB
2025-05-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-05-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 89.0 KB
2025-04-09 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 64.5 KB
2025-04-03 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 90.5 KB
2025-04-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-03-25 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 19.6 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출
Korean 18.0 KB
2025-03-17 00:00
Annual Report
사업보고서 (2024.12)
Korean 437.1 KB
2025-03-17 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1013.2 KB
2025-03-10 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 101.9 KB
2025-02-07 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 7.1 KB

Automate Your Workflow. Get a real-time feed of all TDSPHARM Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TDSPHARM Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TDSPHARM Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

NuCana plc Logo
Develops safer anti-cancer medicines with ProTide technology to overcome cell resistance.
United States of America
NCNA
NUFORMIX PLC Logo
Repurposing drugs for fibrosis and oncology using proprietary cocrystal technology.
United Kingdom
NFX
Nurix Therapeutics, Inc. Logo
Developing protein degradation medicines to treat cancer and autoimmune diseases.
United States of America
NRIX
NUTEX Investments Plc Logo
Develops & distributes health, cosmetic & pharma products from natural ingredients globally.
Hungary
NUTEX
NutriBand Inc. Logo
Develops abuse-deterrent transdermal patches to make potent drug delivery safer.
United States of America
NTRB
Nuvalent, Inc. Logo
Designs targeted small molecule drugs for kinase-driven cancers to overcome treatment resistance.
United States of America
NUVL
Nuvation Bio Inc. Logo
A clinical-stage biopharma developing novel drugs for difficult-to-treat cancers.
United States of America
NUVB
Nxera Pharma Co., Ltd. Logo
Biopharma using SBDD tech to develop medicines for neurology and gastroenterology.
Japan
4565
ObsEva SA Logo
Developed novel therapeutics for women's reproductive health and pregnancy.
Switzerland
OBSN
OCULAR THERAPEUTIX, INC Logo
Develops hydrogel drug delivery therapies for eye diseases like wet AMD and glaucoma.
United States of America
OCUL

Talk to a Data Expert

Have a question? We'll get back to you promptly.